Demographic and clinical characteristics of children in the cohort.

<p>^<i>1</i><i>Indian Rupees</i>,</p><p>^<i>2</i><i>One mother is deceased</i>,</p><p>^<i>3</i><i>Childcare center</i></p><p>Demographic and clinical characteristics of children in the cohort.</p

Associations between log (base2) days of diarrhea and changes in ASQ-scores.

<p>The graphs were constructed using generalized additive models in R, the solid line depicts the association of the total ASQ-score and log (base2) days of diarrhea. The Y-axis is centered on the mean total ASQ-score. The shaded area spans the 95% confidence interval of this association.</p

Demographic and clinical characteristics of children in the cohort.

<p>^<i>1</i><i>Indian Rupees</i>,</p><p>^<i>2</i><i>One mother is deceased</i>,</p><p>^<i>3</i><i>Childcare center</i></p><p>Demographic and clinical characteristics of children in the cohort.</p

Variables predicting ASQ-3 subscale score in North Indian children 12–36 months¹.

<p>*** p<.001,</p><p>** p<.01,</p><p>* p<.05, logistic regression P-value,</p><p>¹ For the 422 assessed children, the mean subscales scores vary from 44.8 to 47.8, all with a range from 0 to 60.</p><p>Variables predicting ASQ-3 subscale score in North Indian children 12–36 months<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0121743#t003fn004" target="_blank">¹</a>.</p

Hierarchical Regression Analysis for variables predicting total ASQ-3 scores in North Indian children 12–36 months¹.

<p>*** p<.001,</p><p>** p<.01,</p><p>* p<.05,</p><p>¹ For the 422 assessed children, the mean total ASQ-3 score was 231.9 (SD = 50) with scores ranging from a minimum of 30 to a maximum of 300.</p><p>^<i>2</i> All models are adjusted for child characteristics (age, sex and breastfeeding status), and annual family income,</p><p>^<i>3</i> unstandardized Beta coefficient,</p><p>^<i>4</i> standardized regression coefficient, Beta values for model 7 only.</p><p>Hierarchical Regression Analysis for variables predicting total ASQ-3 scores in North Indian children 12–36 months<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0121743#t002fn004" target="_blank">¹</a>.</p

Baseline characteristics of Vitamin D deficient and non deficient children aged 6–30 months included in the analysis.

<p>Baseline characteristics of Vitamin D deficient and non deficient children aged 6–30 months included in the analysis.</p

Associations between vitamin-D level at baseline and ALRI incidence density (among 960 children).

<p>The graph was constructed using generalized additive models in R, the solid line depicts the association of vitamin-D level at baseline and ALRI incidence density. The shaded area spans the 95% confidence interval of this association.</p

Associations between vitamin-D level at baseline and weeks of a year (among 960 children).

<p>The graph was constructed using generalized additive models in R, the solid line depicts the association of vitamin-D level at baseline and season. The shaded area spans the 95% confidence interval of this association.</p

Outcome Model for Cost-effectiveness of IMNCI in Haryana, India.

<p><b>Note</b>: In continuation to the model 1, outcome model describes the probable scenarios after a neonatal or post-neonatal infant had been treated or not (irrespective of type of health facility). YLD = Years of life lived with disability, YLL = Years of life lost due to premature mortality, DALY = Disability adjusted life years.</p

ORs¹ (95% CIs)² for being in the lower quartile of ASQ-3 total in the intervention group compared with placebo in subgroups.³

<p>*p<0.05.</p><p>¹Odds Ratio.</p><p>²95% Confidence interval.</p><p>³Adjusted for sex, age, breastfeeding status, stunting and Mother`s encouragement of developmental advances (dichotomus).</p><p>ORs<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0129915#t005fn002" target="_blank">¹</a> (95% CIs)<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0129915#t005fn003" target="_blank">²</a> for being in the lower quartile of ASQ-3 total in the intervention group compared with placebo in subgroups.<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0129915#t005fn004" target="_blank">³</a></p